Research evaluation to study individuals who show thromboxane or P2Y12 receptor resistance
Phase of Trial: Phase IV
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Eptifibatide; Heparin
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- 01 Feb 2013 Planned number of patients changed from 600 to 1200 as reported by ClinicalTrials.gov.
- 19 Jul 2007 Status changed from recruiting to discontinued. Sponsor support withdrawn.
- 21 Jul 2006 New trial record.